Pfizer CEO Slams Kennedy’s Vaccine Stance, Warns China’s Research Dominance
At a WSJ event in Davos, Pfizer CEO Albert Bourla branded Robert F. Kennedy’s vaccine views as “anti-science” and urged replacing the U.S. health secretary to break the policy deadlock. He warned that recent funding cuts have weakened American universities, leaving China with roughly 80% of top-tier global health research roles.
Related News
TOST
Toast Sponsors ICC UK Initiative, Showcases Platform Powering 171,000 Global Locations
TOST•
VBCF
Vanguard’s BondBuilder ETFs Garner $242M, Join $70B Target Maturity Market
VBCF•
VBCH
Vanguard’s BondBuilder Suite Amasses $242M in Two Months, Fuels $70B ETF Segment
VBCH•
PRPO
Precipio Q1 Revenue Rises 30% to $6.71M; Adjusted EBITDA Falls to -$200K
PRPO•
TJX
TJX Beats Q1 EPS by $0.20, Comps Up 6% and Spain Store Launch
TJX•
Sources
FGB